Please login to the form below

Not currently logged in
Email:
Password:

Roche, J&J and Novartis in hepatitis C diagnostics tie-up

Roche signs licensing agreements for Hepatitis C immunodiagnostics with J&J subsidiary Ortho-Clinical Diagnostics and Novartis

Swiss-based pharmaceutical group Roche has signed licensing agreements for Hepatitis C immunodiagnostics with J&J subsidiary Ortho-Clinical Diagnostics and Swiss-headquartered Novartis.

Roche, Ortho-Clinical and Novartis also agreed to settle all litigation related to licensed patents.

Roche will receive a worldwide royalty-bearing license under the deal, according to a Roche statement. Financial terms were not disclosed.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics